Target intelligence / Profile preview

Haematoma resorption process

Molecular classification
Other
01

Overview

Haematoma resorption refers to the physiological process through which extravascular blood and its breakdown products are cleared from tissues following bleeding due to trauma, vascular injury, or surgery. This involves a tightly regulated interplay of immune cells (primarily macrophages and microglia), phagocytosis of red blood cells and degradation products via scavenger receptors (CD163, CD91, CD36), enzymatic breakdown of hemoglobin/heme (by heme oxygenases), and resolution of inflammatory and tissue repair responses. Efficient hematoma clearance is essential for neurological recovery after hemorrhagic brain injury and for successful tissue regeneration following bone fracture. Therapeutic approaches that accelerate hematoma resolution, such as immune cell modulation or administration of neurotrophic factors, are being explored to improve outcomes in conditions like intracerebral hemorrhage and chronic subdural hematoma.

Other names
hematoma resorptionhematoma clearancehematoma absorptionhematoma resolution
02

Mechanism of action

Modulation of immune cell activity (promoting scavenger receptor expression, erythrophagocytosis, anti-inflammatory mediators); Upregulation of pathways such as Nrf2-HO-1, Tie-2 (angiopoietin signaling); Enhanced phagocytosis/endocytosis via receptors like CD163, CD91, CD36

03

Biological functions

Clearance of blood componentsImmune response (phagocytosis by macrophages/microglia)Resolution of inflammationRepair and regeneration post-injury
04

Disease associations

Secondary brain injury (intracerebral hemorrhage)Chronic subdural hematomaDelayed bone healing
05

Safety considerations

Excessive or impaired resorption can lead to secondary injury or delayed healingHeme/hemoglobin neurotoxicity if not adequately clearedDysregulation may cause persistent inflammation or tissue damage
06

Interacting drugs

Recombinant human cerebral dopamine neurotrophic factor (rhCDNF)

1 more in the full profile.

07

Biomarkers

Levels of scavenger receptors on macrophages/microglia (CD163, CD91, CD36)Fibrin/fibrinogen degradation products (FDPs)Hemoglobin and heme clearanceExpression of HO-1 enzyme

Beyond the preview

Go deeper on Haematoma resorption process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haematoma resorption process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call